SNP genotyping and analysis market to reach $46.29 billion by 2030 at 20.1% CAGR, driven by growing burden of genetic diseases & increasing adoption of genetic variation analysis for early diagnosis.
Read MoreSmoking cessation products market to reach $35.59 billion by 2030 at 8.0% CAGR, driven by rising burden of smoking-related diseases and growing health awareness.
Read MoreSmoking cessation and nicotine de-addiction products market to reach $43.12 billion by 2030 at 10.7% CAGR, driven by rising prevalence of smoking-related diseases worldwide.
Read MoreSmall molecule targeted therapy market to reach $120.64 billion by 2030 at 9.3% CAGR, driven by growing emphasis on personalized medicine and molecular-level disease targeting.
Read MoreSmall molecule targeted cancer therapy market to reach $130.9 billion by 2030 at 8.9% CAGR, driven by growing demand for personalized medicine and precision oncology treatments.
Read MoreSmall molecule injectable drugs market to reach $412.35 billion by 2030 at 10.5% CAGR, driven by rising chronic diseases and growing demand for targeted injectable treatments.
Read MoreSmall molecule drug discovery market to reach $117.05 billion by 2030 at 11.6% CAGR, driven by rising incidence of chronic diseases and increasing need for cost-effective therapies.
Read MoreSmall molecule cmo/cdmo market to reach $78.41 billion by 2030 at 7.6% CAGR, driven by rising demand for pharmaceuticals and growing outsourcing of drug manufacturing services.
Read MoreSmall molecule api market to reach $312.83 billion by 2030 at 7.7% CAGR, driven by increasing prevalence of chronic diseases requiring long-term pharmaceutical treatment.
Read MoreSmall molecule active pharmaceutical ingredient market to reach $299.83 billion by 2030 at 7.6% CAGR, driven by increasing prevalence of diseases and rising demand for effective drug formulations.
Read More